focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 12-England goes into new lockdown as COVID-19 variant rampages

Mon, 04th Jan 2021 07:57

* PM Johnson announces tougher restrictions

* Whole of England under "stay at home" order

* Lockdown to last until at least mid-February

* Earlier, UK began rollout of AstraZeneca vaccine
(Adds details)

By William Schomberg and Elizabeth Piper

LONDON, Jan 4 (Reuters) - British Prime Minister Boris
Johnson on Monday ordered England into a new national lockdown
to contain a surge in COVID-19 cases that threatens to overwhelm
parts of the health system before a vaccine programme reaches a
critical mass.

The announcement came just hours after the government hailed
Britain's success in becoming the first country to begin rolling
out the vaccine developed by Oxford University and AstraZeneca
against COVID-19.

Johnson said a new, more contagious variant of the
coronavirus first identified in the United Kingdom and now
present in many other countries was spreading at great speed and
immediate action was needed to slow it down.

"As I speak to you tonight, our hospitals are under more
pressure from COVID than any time since the start of the
pandemic," Johnson said in a televised address to the country.

"With most of the country already under extreme measures,
it's clear that we need to do more together to bring this new
variant under control," he said.

"We must therefore go into a national lockdown, which is
tough enough to contain this variant. That means the government
is once again instructing you to stay at home."

Non-essential shops and hospitality would have to remain
closed, while primary and secondary schools would close from
Tuesday for all pupils except vulnerable children and those
whose parents are key workers.

Johnson said the disruption meant it would not be possible
for all exams to go ahead this summer -- the second academic
year in a row in which the pandemic has played havoc with
pupils' education and future plans.

Johnson said that if the vaccine rollout went as planned and
the number of deaths responded to the lockdown measures as
expected, it should be possible to start moving out of lockdown
by the middle of February.

However, he urged caution about the timetable and appealed
to everyone to comply with the rules.

Britain's economy suffered a historic crash of nearly 20% in
the April-June period of 2020 as swathes of business were
shuttered by the first lockdown.

The new measures, which allow companies such as construction
firms to remain open, could cost about 10% of economic output
for as long as they last, said Julian Jessop, a fellow at the
Institute of Economic Affairs, a think-tank.

NEW VACCINE LAUNCHED

As Britain grapples with the world's sixth highest death
toll and cases hit a new high, the country's chief medical
officers said the spread of COVID-19 risked overwhelming parts
of the health system within 21 days.

The surge in cases has been driven by the new variant of
COVID-19, officials say, and while they acknowledge that the
pandemic is spreading more quickly than expected, they say there
is also light at the end of the tunnel - vaccinations.

Johnson's government earlier touted a scientific "triumph"
as Britain became the first country in the world to start
inoculating people with shots of the Oxford/AstraZeneca vaccine.

Dialysis patient Brian Pinker, 82, received the first
vaccination outside of a trial.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford," said
the retired maintenance manager, just a few hundred metres from
where the vaccine was developed.

But even with the vaccines being rolled out, the number of
COVID-19 cases and deaths keep rising.

More than 75,000 people in the United Kingdom have died from
COVID-19 within 28 days of a positive test since the start of
the pandemic. A record 58,784 new cases of the coronavirus were
reported on Monday.

Moving a few hours ahead of Johnson, Scottish First Minister
Nicola Sturgeon imposed the most stringent lockdown for Scotland
since last spring.

The devolved administration in Wales said all schools and
colleges there should move to online learning until Jan. 18.

(Additional reporting by Estelle Shirbon, Alistair Smout and
Guy Faulconbridge; Editing by Gareth Jones)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.